Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Interest Receivables (2023 - 2025)

iBio (IBIO) has disclosed Change in Interest Receivables for 3 consecutive years, with $20000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Interest Receivables rose 42.86% to $20000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $68000.0, a 11.69% decrease, with the full-year FY2025 number at $62000.0, down 29.55% from a year prior.
  • Change in Interest Receivables was $20000.0 for Q4 2025 at iBio, up from $19000.0 in the prior quarter.
  • In the past five years, Change in Interest Receivables ranged from a high of $22000.0 in Q3 2023 to a low of $14000.0 in Q4 2024.
  • A 3-year average of $18900.0 and a median of $19500.0 in 2024 define the central range for Change in Interest Receivables.
  • Peak YoY movement for Change in Interest Receivables: tumbled 36.36% in 2024, then soared 42.86% in 2025.
  • iBio's Change in Interest Receivables stood at $22000.0 in 2023, then crashed by 36.36% to $14000.0 in 2024, then skyrocketed by 42.86% to $20000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Change in Interest Receivables are $20000.0 (Q4 2025), $19000.0 (Q3 2025), and $15000.0 (Q2 2025).